PTCT PTC Therapeutics, Inc.

$66.06▼ -1.94% Healthcare Other
After hours $65.90▼ -0.24% Sep 11, 7:47 PM ET
Volume 792.9K Avg Volume (10D) 839.4K
Key Metrics & Fundamentals
Market Cap
$5.51B
P/E Ratio
–
Div Yield
–%
52W Range
57.74 - 90.87
% vs 50 MA
-11.49%
% vs 200 MA
-9.71%
RSI-14
33.2
MACD Histogram
-0.3300
Beta (1Y vs SPY)
0.70
Free Cash Flow
$121.97M
Gross Rev
$360.52M
Gross Profit
$340.60M
EBITDA
$161.90M
COGS
$19.92M
Operating Exp
$191.62M
Operating Income
$148.98M
EBIT
$148.98M
Pretax Income
$97.55M
Net Income
$83.50M
EPS (Diluted)
0.92
Price & Volume History
Loading chart…
Recent News
Own Oracle For The AI Boom? PTC's Story Looks Cleaner
Trefis · Sep 4, 2026 9:23 PM
PTC Therapeutics to Participate in Upcoming Investor Conferences
PR Newswire · Aug 27, 2026 12:00 PM
KROS $20M Takeda Milestone Adds Cash but Revenue Visibility Stays Weak
Zacks · Aug 24, 2026 4:53 PM
Should You Buy KROS Stock as Pipeline Promise Meets Revenue Risk?
Zacks · Aug 24, 2026 4:51 PM
PTC Therapeutics Announces New Sephience™ (sepiapterin) Data Reinforcing Broad Patient Benefits Including Sustained Metabolic Control and Diet Liberalization as well as Consistent Favorable Safety Profile
PR Newswire · Aug 24, 2026 12:00 PM
Wells Fargo Sees Up to 52% Upside in 2 Stocks
GuruFocus.com · Aug 17, 2026 6:06 PM
PTC Therapeutics Targets Fabry Gene Therapy in $111M Bankruptcy Auction Deal
MarketBeat · Aug 16, 2026 3:01 PM
PTC takes a chance on Sangamo’s Fabry disease gene therapy
BioPharma Dive · Aug 13, 2026 11:10 AM
PTC to Expand Rare Disease Portfolio with Acquisition of BLA-Stage ST-920 Fabry Disease Program
PR Newswire · Aug 12, 2026 8:01 PM
Sangamo Therapeutics Selects Successful Bidders Following Competitive Asset Auction for $163.55 Million in Cash Consideration at Closing and Up to $100 Million in Potential Milestones
GlobeNewswire · Aug 12, 2026 8:01 PM
Financial Overview - Income Statement Quarterly

See PTCT's money flow as a full page

Social Sentiment
Avg +0.70 · 2 posts
Thoughts on $PTCT
r/stocks · Jul 25, 2025
The comments express optimism regarding FDA approval, positive recent earnings, and a potentially undervalued position due to low chatter, suggesting a bullish sentiment.
positive +0.60
NewsDiscussionPriceTargetDD$PTCT — Quiet Biotech with Major FDA Decision This Monday (July 29)
r/wallstreetbets · Jul 25, 2025
High levels of excitement around an upcoming FDA decision and strong financial metrics.
positive +0.80
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙